Laquinimod Sodium Salt
CAS: 248282-07-7
Ref. 3D-FL159548
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
Laquinimod Sodium Salt
Sinónimos:
- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide sodium salt
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt
- Laquinimod sodium
- ABR 215062 sodium
Descrição:
Laquinimod is a quinoline derivative that is used as a pharmaceutical preparation. It has been shown to be a potent inhibitor of the cb1 receptor, which is responsible for the inflammatory response. Laquinimod also inhibits the phosphorylation of focal adhesion kinase (FAK) and prostaglandin E2 production in mice with colitis. The drug has been shown to have anti-inflammatory effects in several animal models of inflammatory diseases, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), or chronic granulomatous disease.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
378.78 g/mol
Fórmula:
C19H16ClN2NaO3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
